Eduardo Vianna, PhD, MBA
Chief Executive Officer
Eduardo Vianna serves as the company’s CEO. He is a neuroscientist with more than 10 years of experience in research and drug development. Before joining NovaGo, he held global positions of increasing responsibility within Merck Serono and Roche within Medical Affairs, Product Development and Portfolio Management. He has contributed to the successful delivery of the late-stage clinical development program of ocrelizumab for multiple sclerosis. Eduardo has set up and managed global CNS drug development programs, and participated in asset valuation within Portfolio Management. Eduardo Vianna is a pharmacist, and has earned his PhD in Neuroscience from The University of Iowa, USA, and his MBA from the Open University, England.